EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Virtue ethics and the unsettled ethical questions in controlled human infection studies

Jeffrey T Poomkudy iD, Seema K Shah iD

Bioethics · 2024

DOI: 10.1111/bioe.13326 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioethics, 2024. Verfasst von Jeffrey T Poomkudy und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for Bioethics and Medical Humanities, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Virtues, COVID-19, SARS-CoV-2. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Controlled human infection studies (CHIs) involve the intentional infection of human subjects for a scientific aim. Though some past challenge trials have involved serious ethical abuses, in the last few decades, CHIs have had a strong track record of safety. Despite increased attention to the ethics of CHIs during the COVID‐19 pandemic, CHIs remain controversial, and there has been no in‐depth treatment of CHIs through the lens of virtue ethics. In this article, we argue that virtue theory can be helpful for addressing CHIs that present a constellation of controversial, unresolved, and/or under‐regulated ethical issues. We begin with some brief background on virtue ethics. We then substantiate our claim that some CHIs raise a constellation of ethical issues that are unresolved in the ethics literature and/or lack adequate regulatory guidance by demonstrating that CHIs can present indeterminate social value, risks to third parties, limitations on the right to withdraw from research, and questions about the upper limit of allowable risk. We argue that the presence of a virtuous investigator, with virtues such as prudence, compassion, and integrity, is especially important when these unresolved research ethics issues arise, which is the case for certain types of controlled human infection studies. We use the historical example of Walter Reed and the Yellow Fever Commission to illustrate this claim, and we also highlight some contemporary examples. We end by sketching some practical implications of our view, such as ensuring that investigators with experience running CHIs are involved in novel CHI models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VirtuesCOVID-19SARS-CoV-2HumansEthical TheoryEthics, ResearchPandemicsControlled Clinical Trials as TopicSocial Values

Stichwörter der Autor:innen

challenge studiesresearch ethicsvirtue ethics

Autor:innen und Institutionen

  • Center for Bioethics and Medical Humanities, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Smith Child Health Outreach, Research, and Evaluation Center, Stanley Manne Children's Research Institute, Lurie Children's Hospital, Chicago, Illinois, USA.
  • Department of Pediatrics, Northwestern Feinberg School of Medicine, Chicago, Illinois, USA.

ORCID-Profile: Jeffrey T Poomkudy, Seema K Shah

Zitieren

APA

Poomkudy, J. T., & Shah, S. K. (2024). Virtue ethics and the unsettled ethical questions in controlled human infection studies. Bioethics. https://doi.org/10.1111/bioe.13326

Vancouver

Poomkudy JT, Shah SK. Virtue ethics and the unsettled ethical questions in controlled human infection studies. Bioethics. 2024. doi:10.1111/bioe.13326

BibTeX
@article{Poomkudy2024,
  author = {Poomkudy, Jeffrey T and Shah, Seema K},
  title = {Virtue ethics and the unsettled ethical questions in controlled human infection studies},
  journal = {Bioethics},
  year = {2024},
  doi = {10.1111/bioe.13326}
}
Kostenlos starten →